Epidemiology and control of trachoma: systematic review

Abstract

Trachoma is the commonest infectious cause of blindness. Recurrent episodes of infection with serovars A-C of Chlamydia trachomatis cause conjunctival inflammation in children who go on to develop scarring and blindness as adults. It was estimated that in 2002 at least 1.3 million people were blind from trachoma, and currently 40 million people are thought to have active disease and 8.2 million to have trichiasis. The disease is largely found in poor, rural communities in developing countries, particularly in sub-Saharan Africa. The WHO promotes trachoma control through a multifaceted approach involving surgery, mass antibiotic distribution, encouraging facial cleanliness and environmental improvements. This has been associated with significant reductions in the prevalence of active disease over the past 20 years, but there remain a large number of people with trichiasis who are at risk of blindness.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 173

1. 1.

   Adamu Y, Alemayehu W. A randomized clinical trial of the success rates of bilamellar tarsal rotation and tarsotomy for upper eyelid trachomatous trichiasis. Ethiopian Medical Journal. 2002;40:107-114.

   Not in our library

2. 2.

   Alemayehu W, Melese M, Bejiga A, Worku A, Kebede W, Fantaye D. Surgery for trichiasis by ophthalmologists versus integrated eye care workers: a randomized trial. Ophthalmology. 2004;111:578-584.

   Not in our library10.1016/j.ophtha.2003.06.030

3. 3.

   Al-Rifai KM. Trachoma through history. International Ophthalmology. 1988;12:9-14.

   Not in our library10.1007/bf00133774

4. 4.

   Andreasen AA, Burton MJ, Holland MJ, et al. Chlamydia trachomatis ompA variants in trachoma: what do they tell us? PLoS Neglected Tropical Diseases. 2008;2:e306.

   Not in our library10.1371/journal.pntd.0000306

5. 5.

   Anker M, Bessinger R, Holt E, et al. Report of a Technical Meeting on the Use of Lot Quality Assurance Sampling (LQAS) in Polio Eradication Programs. 1998.

   Not in our library

6. 6.

   Astle WF, Wiafe B, Ingram AD, Mwanga M, Glassco CB. Trachoma control in Southern Zambia-an international team project employing the SAFE strategy. Ophthalmic Epidemiology. 2006;13:227-236.

   Not in our library10.1080/09286580600718974

7. 7.

   Bailey R, Osmond C, Mabey DC, Whittle HC, Ward ME. Analysis of the household distribution of trachoma in a Gambian village using a Monte Carlo simulation procedure. International Journal of Epidemiology. 1989;18:944-951.

   Not in our library10.1093/ije/18.4.944

8. 8.

   Bailey R, Downes B, Downes R, Mabey D. Trachoma and water use; a case control study in a Gambian village. Transactions of the Royal Society of Tropical Medicine & Hygiene. 1991;85:824-828.

   Not in our library10.1016/0035-9203(91)90470-j

9. 9.

   Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 1993;342:453-456.

   Not in our library10.1016/0140-6736(93)91591-9

10. 10.

    Bailey RL, Hampton TJ, Hayes LJ, Ward ME, Whittle HC, Mabey DC. Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities. The Journal of Infectious Diseases. 1994;170:709-712.

    Not in our library10.1093/infdis/170.3.709

11. 11.

    Bailey R, Duong T, Carpenter R, Whittle H, Mabey D. The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiology and Infection. 1999;123:479-486.

    Not in our library10.1017/s0950268899003076

12. 12.

    Baral K, Osaki S, Shreshta B, et al. Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. Bulletin of the World Health Organization. 1999;77:461-466.

    Not in our library

13. 13.

    Batt SL, Charalambous BM, Solomon AW, et al. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. Antimicrobial Agents & Chemotherapy. 2003;47:2765-2769.

    Not in our library10.1128/aac.47.9.2765-2769.2003

14. 14.

    Blake IM, Burton MJ, Bailey RL, et al. Estimating household and community transmission of ocular chlamydia trachomatis. PLoS Neglected Tropical Diseases. 2009;3:e401.

    Not in our library10.1371/journal.pntd.0000401

15. 15.

    Bog H, Yorston D, Foster A. Results of community-based eyelid surgery for trichiasis due to trachoma. The British Journal of Ophthalmology. 1993;77:81-83.

    Not in our library10.1136/bjo.77.2.81

16. 16.

    Bowman RJ, Jatta B, Faal H, Bailey R, Foster A, Johnson GJ. Long-term follow-up of lid surgery for trichiasis in the Gambia: surgical success and patient perceptions. Eye (London, England). 2000a;14:864-868.

    Not in our library10.1038/eye.2000.238

17. 17.

    Bowman RJ, Sillah A, Van Dehn C, et al. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Investigative Ophthalmology & Visual Science. 2000b;41:4074-4079.

    Not in our library

18. 18.

    Bowman RJ, Soma OS, Alexander N, et al. Should trichiasis surgery be offered in the village? A community randomised trial of village vs. health centre-based surgery. Tropical Medicine & International Health. 2000c;5:528-533.

    Not in our library10.1046/j.1365-3156.2000.00605.x

19. 19.

    Bowman RJ, Jatta B, Cham B, et al. Natural history of trachomatous scarring in The Gambia: results of a 12-year longitudinal follow-up. Ophthalmology. 2001;108:2219-2224.

    Not in our library10.1016/s0161-6420(01)00645-5

20. 20.

    Bowman RJ, Faal H, Jatta B, et al. Longitudinal study of trachomatous trichiasis in The Gambia: barriers to acceptance of surgery. Investigative Ophthalmology and Visual Science. 2002a;43:936-940.

    Not in our library

21. 21.

    Bowman RJ, Faal H, Myatt M, et al. Longitudinal study of trachomatous trichiasis in the Gambia. The British Journal of Ophthalmology. 2002b;86:339-343.

    Not in our library10.1136/bjo.86.3.339

22. 22.

    Brunham RC, Laga M, Simonsen JN, et al. The prevalence of Chlamydia trachomatis infection among mothers of children with trachoma. American Journal of Epidemiology. 1990;132:946-952.

    Not in our library10.1093/oxfordjournals.aje.a115737

23. 23.
    The Global Burden of Trachoma: A Review · 2009

    No notice
24. 24.

    Burton MJ, Holland MJ, Faal N, et al. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Investigative Ophthalmology & Visual Science. 2003;44:4215-4222.

    Not in our library10.1167/iovs.03-0107

25. 25.

    Burton MJ, Bowman RJ, Faal H, et al. Long term outcome of trichiasis surgery in the Gambia. The British Journal of Ophthalmology. 2005a;89:575-579.

    Not in our library10.1136/bjo.2004.055996

26. 26.

    Burton MJ, Holland MJ, Makalo P, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet. 2005b;365:1321-1328.

    Not in our library10.1016/s0140-6736(05)61029-x

27. 27.

    Burton MJ, Kinteh F, Jallow O, et al. A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia. The British Journal of Ophthalmology. 2005c;89:1282-1288.

    Not in our library10.1136/bjo.2004.062489

28. 28.

    Burton MJ, Bowman RJ, Faal H, et al. The long-term natural history of trachomatous trichiasis in the Gambia. Investigative Ophthalmology & Visual Science. 2006;47:847-852.

    Not in our library10.1167/iovs.05-0714

29. 29.

    Cairncross S, Feachem R. Environmental Health Engineering in the Tropics. 1993.

    Not in our library

30. 30.

    Chern KC, Shrestha SK, Cevallos V, et al. Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. The British Journal of Ophthalmology. 1999;83:1332-1335.

    Not in our library10.1136/bjo.83.12.1332

31. 31.

    Chidambaram JD, Lee DC, Porco TC, Lietman TM. Mass antibiotics for trachoma and the Allee effect. The Lancet Infectious Diseases. 2005;5:194-196.

    Not in our library10.1016/s1473-3099(05)70032-3

32. 32.

    Chidambaram JD, Alemayehu W, Melese M, et al. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. The Journal of the American Medical Association. 2006;295:1142-1146.

    Not in our library10.1001/jama.295.10.1142

33. 33.

    Cochereau I, Goldschmidt P, Goepogui A, et al. Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial. The British Journal of Ophthalmology. 2007;91:667-672.

    Not in our library10.1136/bjo.2006.099275

34. 34.

    Collier LH, Duke-Elder S, Jones BR. Experimental trachoma produced by cultured virus. The British Journal of Ophthalmology. 1958;42:705-720.

    Not in our library10.1136/bjo.42.12.705

35. 35.

    Courtright P. Acceptance of surgery for trichiasis among rural Malawian women. East African Medical Journal. 1994;71:803-804.

    Not in our library

36. 36.

    Cumberland P, Edwards T, Hailu G, et al. The impact of community level treatment and preventative interventions on trachoma prevalence in rural Ethiopia. International Journal of Epidemiology. 2008;37:549-558.

    Not in our library10.1093/ije/dyn045

37. 37.

    Dawson CR, Daghfous T, Messadi M, Hoshiwara I, Schachter J. Severe endemic trachoma in Tunisia. The British Journal of Ophthalmology. 1976;60:245-252.

    Not in our library10.1136/bjo.60.4.245

38. 38.

    Dawson CM, Daghfous R, Juster R, Schachter J. What Clinical Signs are Critical in Evaluating the Impact of Intervention in Trachoma? Chlamydia Infections. 1990.

    Not in our library

39. 39.

    Dawson CR, Schachter J, Sallam S, Sheta A, Rubinstein RA, Washton H. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America. 1997;24:363-368.

    Not in our library10.1093/clinids/24.3.363

40. 40.

    Desmond N, Solomon AW, Massae PA, et al. Acceptability of azithromycin for the control of trachoma in Northern Tanzania. Transactions of the Royal Society of Tropical Medicine & Hygiene. 2005;99:656-663.

    Not in our library10.1016/j.trstmh.2005.03.006

41. 41.

    Diamant J, Benis R, Schachter J, et al. Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection. Ophthalmic Epidemiology. 2001;8:109-117.

    Not in our library10.1076/opep.8.2.109.4156

42. 42.

    Dolin PJ, Faal H, Johnson GJ, et al. Reduction of trachoma in a sub-Saharan village in absence of a disease control programme. Lancet. 1997;349:1511-1512.

    Not in our library10.1016/s0140-6736(97)01355-x

43. 43.

    Dolin PJ, Faal H, Johnson GJ, Ajewole J, Mohamed AA, Lee PS. Trachoma in The Gambia. The British Journal of Ophthalmology. 1998;82:930-933.

    Not in our library10.1136/bjo.82.8.930

44. 44.

    El Toukhy E, Lewallen S, Courtright P. Routine bilamellar tarsal rotation surgery for trachomatous trichiasis: short-term outcome and factors associated with surgical failure. Ophthalmic Plastic & Reconstructive Surgery. 2006;22:109-112.

    Not in our library10.1097/01.iop.0000203494.49446.60

45. 45.

    Emerson PM, Lindsay SW, Walraven GE, et al. Effect of fly control on trachoma and diarrhoea. Lancet. 1999;353:1401-1403.

    Not in our library10.1016/s0140-6736(98)09158-2

46. 46.

    Emerson PM, Cairncross S, Bailey RL, Mabey DC. Review of the evidence base for the ‘F’ and ‘E’ components of the SAFE strategy for trachoma control. Tropical Medicine & International Health. 2000;5:515-527.

    Not in our library10.1046/j.1365-3156.2000.00603.x

47. 47.

    Emerson PM, Lindsay SW, Alexander N, et al. Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet. 2004;363:1093-1098.

    Not in our library10.1016/s0140-6736(04)15891-1

48. 48.

    Frick KD, Lietman TM, Holm SO, Jha HC, Chaudhary JS, Bhatta RC. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. Bulletin of the World Health Organization. 2001a;79:201-207.

    Not in our library

49. 49.

    Frick KD, Melia BM, Buhrmann RR, West SK. Trichiasis and disability in a trachoma-endemic area of Tanzania. Archives of Ophthalmology. 2001b;119:1839-1844.

    Not in our library10.1001/archopht.119.12.1839

50. 50.

    Frick KD, Basilion EV, Hanson CL, Colchero MA. Estimating the burden and economic impact of trachomatous visual loss. Ophthalmic Epidemiology. 2003a;10:121-132.

    Not in our library10.1076/opep.10.2.121.13899

51. 51.

    Frick KD, Hanson CL, Jacobson GA. Global burden of trachoma and economics of the disease. The American Journal of Tropical Medicine & Hygiene. 2003b;69:1-10.

    Not in our library10.4269/ajtmh.2003.69.5_suppl_1.0690001

52. 52.

    Fry AM, Jha HC, Lietman TM, et al. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America. 2002;35:395-402.

    Not in our library10.1086/341414

53. 53.

    Gaynor BD, Yi E, Lietman T. Rationale for mass antibiotic distribution for trachoma elimination. International Ophthalmology Clinics. 2002;42:85-92.

    Not in our library10.1097/00004397-200201000-00012

54. 54.

    Gaynor BD, Holbrook KA, Whitcher JP, et al. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year. The British Journal of Ophthalmology. 2003a;87:147-148.

    Not in our library10.1136/bjo.87.2.147

55. 55.
    Eliminating Trachoma in Areas with Limited Disease · 2003

    Not checked
56. 56.

    Gaynor BD, Chidambaram JD, Cevallos V, et al. Topical ocular antibiotics induce bacterial resistance at extraocular sites. The British Journal of Ophthalmology. 2005;89:1097-1099.

    Not in our library10.1136/bjo.2005.068981

57. 57.

    Gower EW, Solomon AW, Burton MJ, et al. Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment. Investigative Ophthalmology & Visual Science. 2006;47:4767-4771.

    Not in our library10.1167/iovs.05-1599

58. 58.

    Grassly NC, Ward ME, Ferris S, Mabey DC, Bailey RL. The natural history of trachoma infection and disease in a gambian cohort with frequent follow-up. PLoS Neglected Tropical Diseases. 2008;2:e341.

    Not in our library10.1371/journal.pntd.0000341

59. 59.

    Gray RH, Wabwire-Mangen F, Kigozi G, et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. American Journal of Obstetrics & Gynecology. 2001;185:1209-1217.

    Not in our library10.1067/mob.2001.118158

60. 60.

    Graz B, Xu JM, Yao ZS, Han SR, Kok A. Trachoma: can trichiasis be treated with a sticking-plaster? A randomized clinical trial in China. Tropical Medicine & International Health. 1999;4:222-228.

    Not in our library10.1046/j.1365-3156.1999.43375.x

61. 61.

    Habte D, Gebre T, Zerihun M, Assefa Y. Determinants of uptake of surgical treatment for trachomatous trichiasis in North Ethiopia. Ophthalmic Epidemiology. 2008;15:328-333.

    Not in our library10.1080/09286580801974897

62. 62.

    Harding-Esch EM, Edwards T, Sillah A, et al. Risk factors for active trachoma in The Gambia. Transactions of the Royal Society of Tropical Medicine & Hygiene. 2008;102:1255-1262.

    Not in our library10.1016/j.trstmh.2008.04.022

63. 63.

    Haylor HR. Trahcoma: A Blinding Scourge from the Bronze Age to the Twenty-First Century. 2008.

    Not in our library

64. 64.

    Hirschberg J. The History of Ophthalmology in Eleven Volumes. 1: Antiquity. 1982.

    Not in our library

65. 65.

    Hoechsmann A, Metcalfe N, Kanjaloti S, et al. Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi. Ophthalmic Epidemiology. 2001;8:145-153.

    Not in our library10.1076/opep.8.2.145.4169

66. 66.

    Holm SO, Jha HC, Bhatta RC, et al. Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. Bulletin of the World Health Organization. 2001;79:194-200.

    Not in our library

67. 67.

    Hong KC, Schachter J, Moncada J, Zhou Z, House J, Lietman TM. Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma. Emerging Infectious Diseases. 2009;15:1088-1090.

    Not in our library10.3201/eid1507.081563

68. 68.

    House JI, Ayele B, Porco TC, et al. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial. Lancet. 2009;373:1111-1118.

    Not in our library10.1016/s0140-6736(09)60323-8

69. 69.

    Huguet P, Bella L, Einterz E, Goldschmidt P, Bensaid P. Trachoma mass treatment with azithromycin 1.5% eye drops in Cameroon: feasibility, tolerance and effectiveness. The British Journal of Ophthalmology. 2010;94:157-160.

    Not in our library10.1136/bjo.2009.161513

70. 70.

    Jones BR. The prevention of blindness from trachoma. Transactions of the Ophthalmological Societies of the United Kingdom. 1975;95:16-33.

    Not in our library

71. 71.

    Katz J, Zeger SL, Tielsch JM. Village and household clustering of xerophthalmia and trachoma. International Journal of Epidemiology. 1988;17:865-869.

    Not in our library10.1093/ije/17.4.865

72. 72.

    King JD, Ngondi J, Gatpan G, Lopidia B, Becknell S, Emerson PM. The burden of trachoma in ayod county of southern Sudan. PLoS Neglected Tropical Diseases. 2008;2:e299.

    Not in our library10.1371/journal.pntd.0000299

73. 73.

    Kuper H, Solomon AW, Buchan J, Zondervan M, Foster A, Mabey D. A critical review of the SAFE strategy for the prevention of blinding trachoma. Lancet Infectious Diseases. 2003;3:372-381.

    Not in our library10.1016/s1473-3099(03)00659-5

74. 74.

    Kupka K, Nizetic B, Reinhards J. Sampling studies on the epidemiology and control of trachoma in southern Morocco. Bulletin of the World Health Organization. 1968;39:547-566.

    Not in our library

75. 75.

    Lakew T, Alemayehu W, Melese M, et al. Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution. PLoS Neglected Tropical Diseases. 2009a;3:e507.

    Not in our library10.1371/journal.pntd.0000507

76. 76.

    Lakew T, House J, Hong KC, et al. Reduction and return of infectious trachoma in severely affected communities in ethiopia. PLoS Neglected Tropical Diseases. 2009b;3:e376.

    Not in our library10.1371/journal.pntd.0000376

77. 77.

    Laming AC, Currie BJ, Difrancesco M, Taylor HR, Mathews JD. A targeted, single-dose azithromycin strategy for trachoma. The Medical Journal of Australia. 2000;172:163-166.

    Not in our library10.5694/j.1326-5377.2000.tb125541.x

78. 78.

    Lansingh VC, Carter MJ. Trachoma surveys 2000–2005: results, recent advances in methodology, and factors affecting the determination of prevalence. Survey of Ophthalmology. 2007;52:535-546.

    Not in our library10.1016/j.survophthal.2007.06.007

79. 79.

    Leach AJ, Shelby-James TM, Mayo M, et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America. 1997;24:356-362.

    Not in our library10.1093/clinids/24.3.356

80. 80.

    Lee S, Alemayehu W, Melese M, et al. Chlamydia on children and flies after mass antibiotic treatment for trachoma. The American Journal of Tropical Medicine & Hygiene. 2007;76:129-131.

    Not in our library

81. 81.

    Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nature Medicine. 1999;5:572-576.

    Not in our library10.1038/8451

82. 82.

    Lietman TM, Dawson CR, Osaki SY, Zegans ME. Clinically active trachoma versus actual Chlamydial infection. The Medical Journal of Australia. 2000;172:93-94.

    Not in our library10.5694/j.1326-5377.2000.tb139214.x

83. 83.

    Limburg H, Bah M, Johnson GJ. Trial of the Trachoma Rapid Assessment methodology in The Gambia. Ophthalmic Epidemiology. 2001;8:73-85.

    Not in our library10.1076/opep.8.2.73.4157

84. 84.

    Liu H, Ou B, Paxton A, et al. Rapid assessment of trachoma in Hainan Province, China: validation of the new World Health Organization methodology. Ophthalmic Epidemiology. 2002;9:97-104.

    Not in our library10.1076/opep.9.2.97.1521

85. 85.

    Luna EJ, Medina NH, Oliveira B, et al. Epidemiology of trachoma in Bebedouro State of Sao Paulo, Brazil: prevalence and risk factors. International Journal of Epidemiology. 1992;21:169-177.

    Not in our library10.1093/ije/21.1.169

86. 86.

    Lynch M, West SK, Munoz B, Kayongoya A, Taylor HR, Mmbaga BB. Testing a participatory strategy to change hygiene behaviour: face washing in central Tanzania. Transactions of the Royal Society of Tropical Medicine & Hygiene. 1994;88:513-517.

    Not in our library10.1016/0035-9203(94)90141-4

87. 87.

    Mabey DC, Solomon AW, Foster A. Trachoma. Lancet. 2003;362:223-229.

    Not in our library10.1016/s0140-6736(03)13914-1

88. 88.

    Maccallan AF. The epidemiology of trachoma. The British Journal of Ophthalmology. 1931;15:369-411.

    Not in our library10.1136/bjo.15.7.369

89. 89.

    Malaty R, Zaki S, Said ME, Vastine DW, Dawson DW, Schachter J. Extraocular infections in children in areas with endemic trachoma. The Journal of Infectious Diseases. 1981;143:853.

    Not in our library10.1093/infdis/143.6.853

90. 90.

    Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. The British Journal of Ophthalmology. 2009;93:563-568.

    Not in our library10.1136/bjo.2008.148494

91. 91.

    Mathur GM, Sharma R. Influence of some socio-economic factors on the prevalence of trachoma. Indian Journal of Medical Sciences. 1970;24:325-334.

    Not in our library

92. 92.

    Melese M, Alemayehu W, Friedlander E, Courtright P. Indirect costs associated with accessing eye care services as a barrier to service use in Ethiopia. Tropical Medicine & International Health. 2004a;9:426-431.

    Not in our library10.1111/j.1365-3156.2004.01205.x

93. 93.

    Melese M, Chidambaram JD, Alemayehu W, et al. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. The Journal of the American Medical Association. 2004b;292:721-725.

    Not in our library10.1001/jama.292.6.721

94. 94.

    Melese M, Alemayehu W, Lakew T, et al. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. The Journal of the American Medical Association. 2008;299:778-784.

    Not in our library10.1001/jama.299.7.778

95. 95.

    Merbs SL, West SK, West ES. Pattern of recurrence of trachomatous trichiasis after surgery surgical technique as an explanation. Ophthalmology. 2005;112:705-709.

    Not in our library10.1016/j.ophtha.2004.10.037

96. 96.

    Michel CE, Solomon AW, Magbanua JP, et al. Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study. Lancet. 2006;367:1585-1590.

    Not in our library10.1016/s0140-6736(06)68695-9

97. 97.

    Miller K, Pakpour N, Yi E, et al. Pesky trachoma suspect finally caught. The British Journal of Ophthalmology. 2004a;88:750-751.

    Not in our library10.1136/bjo.2003.038661

98. 98.

    Miller K, Schmidt G, Melese M, et al. How reliable is the clinical exam in detecting ocular chlamydial infection? Ophthalmic Epidemiology. 2004b;11:255-262.

    Not in our library10.1080/09286580490514577

99. 99.

    Munoz B, Bobo L, Mkocha H, Lynch M, Hsieh YH, West S. Incidence of trichiasis in a cohort of women with and without scarring. International Journal of Epidemiology. 1999;28:1167-1171.

    Not in our library10.1093/ije/28.6.1167

100. 100.

     Munoz B, Solomon AW, Zingeser J, et al. Antibiotic dosage in trachoma control programs: height as a surrogate for weight in children. Investigative Ophthalmology & Visual Science. 2003;44:1464-1469.

     Not in our library10.1167/iovs.02-0234

101. 101.

     Myatt M, Limburg H, Minassian D, Katyola D. Field trial of applicability of lot quality assurance sampling survey method for rapid assessment of prevalence of active trachoma. Bulletin of the World Health Organization. 2003;81:877-885.

     Not in our library

102. 102.

     Myatt M, Mai NP, Quynh NQ, et al. Using lot quality-assurance sampling and area sampling to identify priority areas for trachoma control: Viet Nam. Bulletin of the World Health Organization. 2005;83:756-763.

     Not in our library

103. 103.

     Negrel AD, Mariotti SP. Trachoma rapid assessment: rationale and basic principles. Community Eye Health. 1999;12:51-53.

     Not in our library

104. 104.

     Negrel AD, Taylor HR, West S. Guidelines for Rapid Assessment for Blinding Trachoma. 2001.

     Not in our library

105. 105.

     Ngondi J, Ole-Sempele F, Onsarigo A, et al. Blinding trachoma in postconflict southern Sudan. PLoS Medicine. 2006a;3:e478.

     Not in our library10.1371/journal.pmed.0030478

106. 106.

     Ngondi J, Ole-Sempele F, Onsarigo A, et al. Prevalence and causes of blindness and low vision in southern Sudan. PLoS Medicine. 2006b;3:e477.

     Not in our library10.1371/journal.pmed.0030477

107. 107.

     Ngondi J, Onsarigo A, Matthews F, et al. Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study. Lancet. 2006c;368:589-595.

     Not in our library10.1016/s0140-6736(06)69202-7

108. 108.

     Ngondi J, Reacher M, Matthews F, et al. The epidemiology of low vision and blindness associated with trichiasis in southern Sudan. BMC Ophthalmology. 2007;7:12.

     Not in our library10.1186/1471-2415-7-12

109. 109.

     Ngondi J, Matthews F, Reacher M, Baba S, Brayne C, Emerson P. Associations between active trachoma and community intervention with antibiotics, facial cleanliness, and environmental improvement (A,F,E). PLoS Neglectd Tropical Diseases. 2008;2:e229.

     Not in our library10.1371/journal.pntd.0000229

110. 110.

     Ngondi J, Gebre T, Shargie EB, et al. 2009a.

     Not in our library

111. 111.

     Ngondi J, Reacher M, Matthews F, Brayne C, Emerson P. Trachoma survey methods: a literature review. Bulletin of the World Health Organization. 2009b;87:143-151.

     Not in our library10.2471/blt.07.046326

112. 112.

     Paxton A. Rapid assessment of trachoma prevalence – Singida, Tanzania. A study to compare assessment methods. Ophthalmic Epidemiology. 2001;8:87-96.

     Not in our library10.1076/opep.8.2.87.4166

113. 113.

     Peach H, Piper S, Devanesen D, Al E. 1987.

     Not in our library

114. 114.

     Pitsouni E, Iavazzo C, Athanasiou S, Falagas ME. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. International Journal of Antimicrobial Agents. 2007;30:213-221.

     Not in our library10.1016/j.ijantimicag.2007.04.015

115. 115.

     Polack S, Brooker S, Kuper H, Mariotti S, Mabey D, Foster A. Mapping the global distribution of trachoma. Bulletin of the World Health Organization. 2005;83:913-919.

     Not in our library

116. 116.

     Porco TC, Gebre T, Ayele B, et al. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. The Journal of the American Medical Association. 2009;302:962-968.

     Not in our library10.1001/jama.2009.1266

117. 117.

     Rabiu M, Alhassan M, Ejere H. Environmental sanitary interventions for preventing active trachoma. Cochrane Database of Systematic Reviews. 2007.

     Not in our library10.1002/14651858.cd004003.pub3

118. 118.

     Ray KJ, Porco TC, Hong KC, et al. A rationale for continuing mass antibiotic distributions for trachoma. BMC Infectious Diseases. 2007;7:91.

     Not in our library10.1186/1471-2334-7-91

119. 119.
     When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries. · 2009

     Not checked
120. 120.

     Reacher MH, Munoz B, Alghassany A, Daar AS, Elbualy M, Taylor HR. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Archives of Ophthalmology. 1992;110:667-674.

     Not in our library10.1001/archopht.1992.01080170089030

121. 121.

     Reacher M, Foster A, Huber MJ. Trichiasis Surgery for Trachoma. The Bilamellar Tarsal Rotation Procedure. 1993.

     Not in our library

122. 122.

     Resnikoff S, Peyramaure F, Bagayogo CO, Huguet P. 1995;72:89-98.

     Not in our library

123. 123.

     Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bulletin of the World Health Organization. 2004;82:844-851.

     Not in our library

124. 124.

     Sahlu T, Larson C. The prevalence and environmental risk factors for moderate and severe trachoma in southern Ethiopia. The Journal of Tropical Medicine & Hygiene. 1992;95:36-41.

     Not in our library

125. 125.

     Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet. 1999;354:630-635.

     Not in our library10.1016/s0140-6736(98)12387-5

126. 126.

     Schemann JF, Sacko D, Malvy D, et al. Risk factors for trachoma in Mali. International Journal of Epidemiology. 2002;31:194-201.

     Not in our library10.1093/ije/31.1.194

127. 127.

     Solomon AW, Holland MJ, Burton MJ, et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet. 2003;362:198-204.

     Not in our library10.1016/s0140-6736(03)13909-8

128. 128.

     Solomon AW, Holland MJ, Alexander ND, et al. Mass treatment with single-dose azithromycin for trachoma. The New England Journal of Medicine. 2004a;351:1962-1971.

     Not in our library10.1056/nejmoa040979

129. 129.

     Solomon AW, Peeling RW, Foster A, Mabey DC. Diagnosis and assessment of trachoma. Clinical Microbiology Reviews. 2004b;17:982-1011.

     Not in our library10.1128/cmr.17.4.982-1011.2004

130. 130.

     Solomon AW, Mohammed Z, Massae PA, et al. Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis. Antimicrobial Agents & Chemotherapy. 2005;49:4804-4806.

     Not in our library10.1128/aac.49.11.4804-4806.2005

131. 131.

     Solomon AW, Harding-Esch E, Alexander ND, et al. Two doses of azithromycin to eliminate trachoma in a Tanzanian community. The New England Journal of Medicine. 2008;358:1870-1871.

     Not in our library10.1056/nejmc0706263

132. 132.

     Tabbara KF, Abu-El-Asrar A, Al-Omar O, Choudhury AH, Al-Faisal Z. Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study. Ophthalmology. 1996;103:842-846.

     Not in our library10.1016/s0161-6420(96)30605-2

133. 133.

     Tang FF, Huang YT, Chang HL, Wong C. Isolation of trachoma virus in chick embryo. Journal of Hygiene, Epidemiology, Microbiology & Immunology. 1957;1:109-120.

     Not in our library

134. 134.

     Taylor HR, Velasco FM, Sommer A. The ecology of trachoma: an epidemiological study in southern Mexico. Bulletin of the World Health Organization. 1985;63:559-567.

     Not in our library

135. 135.

     Taylor HR, West SK, Mmbaga BB, et al. Hygiene factors and increased risk of trachoma in central Tanzania. Archives of Ophthalmology. 1989;107:1821-1825.

     Not in our library10.1001/archopht.1989.01070020903037

136. 136.

     Tellis B, Keeffe JE, Taylor HR. Surveillance report for active trachoma, 2006: National Trachoma Surveillance and Reporting Unit. Communicable Diseases Intelligence. 2007;31:366-374.

     Not in our library10.33321/cdi.2007.31.38

137. 137.

     Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bulletin of the World Health Organization. 1987;65:477-483.

     Not in our library

138. 138.

     Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bulletin of the World Health Organization. 1995;73:115-121.

     Not in our library

139. 139.

     Tielsch JM, West KP, Katz J, et al. The epidemiology of trachoma in southern Malawi. The American Journal of Tropical Medicine & Hygiene. 1988;38:393-399.

     Not in our library10.4269/ajtmh.1988.38.393

140. 140.

     Tiwari T, Murphy TV, Moran J. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR. Recommendations and reports: morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2005;54:1-16.

     Not in our library

141. 141.

     Turner VM, West SK, Munoz B, et al. Risk factors for trichiasis in women in Kongwa, Tanzania: a case-control study. International Journal of Epidemiology. 1993;22:341-347.

     Not in our library10.1093/ije/22.2.341

142. 142.

     Ward M, Bailey R, Lesley A, Kajbaf M, Robertson J, Mabey D. Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia. Scandinavian Journal of Infectious Diseases. Supplementum. 1990;69:137-148.

     Not in our library

143. 143.

     West SK. Azithromycin for control of trachoma. Community Eye Health. 1999;12:55-56.

     Not in our library

144. 144.

     West SK. Trachoma: new assault on an ancient disease. Progress in Retinal & Eye Research. 2004;23:381-401.

     Not in our library10.1016/j.preteyeres.2004.04.001

145. 145.

     West S, Lynch M, Turner V, et al. Water availability and trachoma. Bulletin of the World Health Organization. 1989;67:71-75.

     Not in our library

146. 146.

     West SK, Congdon N, Katala S, Mele L. Facial cleanliness and risk of trachoma in families. Archives of Ophthalmology. 1991a;109:855-857.

     Not in our library10.1001/archopht.1991.01080060119038

147. 147.

     West SK, Munoz B, Turner VM, Mmbaga BB, Taylor HR. The epidemiology of trachoma in central Tanzania. International Journal of Epidemiology. 1991b;20:1088-1092.

     Not in our library10.1093/ije/20.4.1088

148. 148.

     West S, Munoz B, Bobo L, et al. Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area. Investigative Ophthalmology & Visual Science. 1993;34:3194-3198.

     Not in our library

149. 149.

     West S, Lynch M, Munoz B, Katala S, Tobin S, Mmbaga BB. Predicting surgical compliance in a cohort of women with trichiasis. International Ophthalmology. 1994;18:105-109.

     Not in our library10.1007/bf00919249

150. 150.

     West S, Munoz B, Lynch M, et al. Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet. 1995;345:155-158.

     Not in our library10.1016/s0140-6736(95)90167-1

151. 151.

     West SK, Munoz B, Mkocha H, Hsieh YH, Lynch MC. Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiology. 2001;8:137-144.

     Not in our library10.1076/opep.8.2.137.4158

152. 152.

     West ES, Munoz B, Mkocha H, et al. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Investigative Ophthalmology & Visual Science. 2005a;46:83-87.

     Not in our library10.1167/iovs.04-0327

153. 153.

     West SK, Munoz B, Mkocha H, et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet. 2005b;366:1296-1300.

     Not in our library10.1016/s0140-6736(05)67529-0

154. 154.

     West ES, Munoz B, Imeru A, Alemayehu W, Melese M, West SK. The association between epilation and corneal opacity among eyes with trachomatous trichiasis. The British Journal of Ophthalmology. 2006a;90:171-174.

     Not in our library10.1136/bjo.2005.075390

155. 155.

     West SK, Emerson PM, Mkocha H, et al. Intensive insecticide spraying for fly control after mass antibiotic treatment for trachoma in a hyperendemic setting: a randomised trial. Lancet. 2006b;368:596-600.

     Not in our library10.1016/s0140-6736(06)69203-9

156. 156.

     West SK, West ES, Alemayehu W, et al. Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia. Archives of Ophthalmology. 2006c;124:309-314.

     Not in our library10.1001/archopht.124.3.309

157. 157.

     West S, Alemayehu W, Munoz B, Gower EW. Azithromycin prevents recurrence of severe trichiasis following trichiasis surgery: STAR trial. Ophthalmic Epidemiology. 2007a;14:273-277.

     Not in our library10.1080/09286580701410323

158. 158.

     West SK, Munoz B, Mkocha H, Gaydos C, Quinn T. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village. Investigative Ophthalmology & Visual Science. 2007b;48:1492-1497.

     Not in our library10.1167/iovs.06-0625

159. 159.

     Planning for the Global Elimination of Trachoma (GET). 1997.

     Not in our library

160. 160.

     Report of the Eighth Meeting of the WHO Alliance for the Global Elimination of Blinding Trachoma. 2004.

     Not in our library

161. 161.

     Trachoma Control – A Guide for Programme Managers. 2006.

     Not in our library

162. 162.

     The Global Burden of Disease: 2004 Update. 2008.

     Not in our library

163. 163.

     Joint Research Agenda Meeting for the Elimination of Blinding Trachoma. 2004.

     Not in our library

164. 164.

     Wolle MA, Munoz B, Mkocha H, West SK. Age, sex, and cohort effects in a longitudinal study of trachomatous scarring. Investigative Ophthalmology & Visual Science. 2009;50:592-596.

     Not in our library10.1167/iovs.08-2414

165. 165.

     Wright HR, Taylor HR. Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us? Lancet Infectious Diseases. 2005;5:313-320.

     Not in our library10.1016/s1473-3099(05)70116-x

166. 166.

     Wright HR, Vu H, Taylor HR. How to assess the prevalence of trachoma. The British Journal of Ophthalmology. 2005;89:526-527.

     Not in our library10.1136/bjo.2005.066183

167. 167.

     Wright HR, Turner A, Taylor HR. Trachoma. Lancet. 2008;371:1945-1954.

     Not in our library10.1016/s0140-6736(08)60836-3

168. 168.

     Yorston D, Mabey D, Hatt S, Burton M. Interventions for trachoma trichiasis. Cochrane Database of Systematic Reviews. 2006;3.

     Not in our library10.1002/14651858.cd004008.pub2

169. 169.

     Zack R, Mkocha H, Zack E, Munoz B, West SK. Issues in defining and measuring facial cleanliness for national trachoma control programs. Transactions of the Royal Society of Tropical Medicine & Hygiene. 2008;102:426-431.

     Not in our library10.1016/j.trstmh.2008.02.001

170. 170.

     Zerihun N. Trachoma in Jimma zone, south western Ethiopia. Tropical Medicine & International Health. 1997;2:1115-1121.

     Not in our library10.1046/j.1365-3156.1997.d01-211.x

171. 171.

     Zhang H, Kandel RP, Sharma B, Dean D. Risk factors for recurrence of postoperative trichiasis: implications for trachoma blindness prevention. Archives of Ophthalmology. 2004a;122:511-516.

     Not in our library10.1001/archopht.122.4.511

172. 172.

     Zhang J, Lietman T, Olinger L, Miao Y, Stephens RS. Genetic diversity of Chlamydia trachomatis and the prevalence of trachoma. The Pediatric Infectious Disease Journal. 2004b;23:217-220.

     Not in our library10.1097/01.inf.0000115501.60397.a6

173. 173.

     Zhang H, Kandel RP, Atakari HK, Dean D. Impact of oral azithromycin on recurrence of trachomatous trichiasis in Nepal over 1 year. The British Journal of Ophthalmology. 2006;90:943-948.

     Not in our library10.1136/bjo.2006.093104

Cited by papers we hold 2

• Burden of disease from inadequate water, sanitation and hygiene for selected adverse health outcomes: An updated analysis with a focus on low- and middle-income countries · 2019
  No notice
• Effect of Water, Sanitation, and Hygiene on the Prevention of Trachoma: A Systematic Review and Meta-Analysis · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.